Publications by authors named "Anthony Goncalves"

100Publications

The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017.

Eur J Cancer 2021 Jan 4;145:11-18. Epub 2021 Jan 4.

Institut Paoli Calmettes, SESSTIM UMR1252, Aix Marseille Univ, INSERM, IRD, Marseille, France. Electronic address:

View Article and Find Full Text PDF
January 2021

Deterioration of Sexual Health in Cancer Survivors Five Years after Diagnosis: Data from the French National Prospective VICAN Survey.

Cancers (Basel) 2020 Nov 20;12(11). Epub 2020 Nov 20.

APHM, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Equipe CANBIOS Labellisée Ligue Contre le Cancer, Hop Timone, BioSTIC, Biostatistique et Technologies de l'Information et de la Communication, Aix Marseille Univ, 13005 Marseille, France.

View Article and Find Full Text PDF
November 2020

[PARP inhibitors in breast cancer: Current clinical development and perspectives].

Bull Cancer 2020 Oct 28;107(10):1024-1041. Epub 2020 Sep 28.

Aix-Marseille Université, Institut Paoli-Calmettes, CNRS, département d'Oncologie Médicale, CRCM, Inserm, 232, boulevard Sainte-Marguerite, BP 156, 13273 Marseille cedex 9, France. Electronic address:

View Article and Find Full Text PDF
October 2020

Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results.

Curr Opin Oncol 2020 Nov;32(6):585-593

Medical Oncology Department, Institut Paoli-Calmettes, Aix-Marseille University, INSERM, CNRS, CRCM.

View Article and Find Full Text PDF
November 2020

Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.

Int J Cancer 2021 Jan 6;148(2):375-384. Epub 2020 Aug 6.

EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), Saint-Denis, France.

View Article and Find Full Text PDF
January 2021

New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi.

Cancers (Basel) 2020 Jun 14;12(6). Epub 2020 Jun 14.

Department of Medical Oncology, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France.

View Article and Find Full Text PDF
June 2020

PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?

Cancers (Basel) 2020 May 27;12(6). Epub 2020 May 27.

Medical Oncology Department, Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France.

View Article and Find Full Text PDF
May 2020

The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype.

NPJ Breast Cancer 2020 6;6. Epub 2020 Mar 6.

Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.

View Article and Find Full Text PDF
March 2020

Paclitaxel Response Can Be Predicted With Interpretable Multi-Variate Classifiers Exploiting DNA-Methylation and miRNA Data.

Front Genet 2019 25;10:1041. Epub 2019 Oct 25.

Cancer Research Center of Marseille, CRCM, INSERM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, Paris, France.

View Article and Find Full Text PDF
October 2019

Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer.

Cancers (Basel) 2019 Sep 29;11(10). Epub 2019 Sep 29.

EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), 143 Boulevard Anatole, 93200 Saint-Denis, France.

View Article and Find Full Text PDF
September 2019

[E-health and "Cancer outside the hospital walls", Big Data and artificial intelligence].

Bull Cancer 2020 Jan 19;107(1):102-112. Epub 2019 Sep 19.

Institut Paoli-Calmettes, département d'oncologie médicale, 13009 Marseille, France; Aix-Marseille université, Centre de recherche en cancérologie de Marseille, Inserm U1068-CNRS U7258, 13009 Marseille, France.

View Article and Find Full Text PDF
January 2020

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers.

Cancers (Basel) 2019 Aug 13;11(8). Epub 2019 Aug 13.

Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Univ, CRCM, CNRS, INSERM, 13000 Marseille, France.

View Article and Find Full Text PDF
August 2019

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review.

Cancers (Basel) 2019 Jul 22;11(7). Epub 2019 Jul 22.

Department of Medical Oncology, Aix-Marseille University, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, 13009 Marseille, France.

View Article and Find Full Text PDF
July 2019

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.

Cancers (Basel) 2019 May 13;11(5). Epub 2019 May 13.

Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France.

View Article and Find Full Text PDF
May 2019

Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on "Cancer outside the Hospital Walls".

Cancers (Basel) 2019 Feb 14;11(2). Epub 2019 Feb 14.

Aix-Marseille Univ, INSERM U1068, CNRS UMR7258, Département d'Oncologie Médicale, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France.

View Article and Find Full Text PDF
February 2019

Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.

JAMA Netw Open 2019 01 4;2(1):e187147. Epub 2019 Jan 4.

Health Product Epidemiology Department, French National Agency for Medicines and Health Products Safety, Saint-Denis, France.

View Article and Find Full Text PDF
January 2019

Targeting Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

Cancers (Basel) 2018 Dec 11;10(12). Epub 2018 Dec 11.

Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.

View Article and Find Full Text PDF
December 2018

Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial.

JCO Precis Oncol 2018 19;2. Epub 2018 Oct 19.

, , , , , , , , , , , , , , , , , and , Institut Curie, Paris; , , , , , , , , , , , , , and , Institut Curie; , Institut National de la Santé et de la Recherche Médicale U900 Research Unit, Saint-Cloud; , Institut Paoli-Calmettes, Marseille; , Centre Léon Bérard, Lyon; , Centre Alexis Vautrin, Nancy; , Institut Claudius Régaud, Toulouse; , Centre René Gauducheau, Nantes; , Centre Georges-François Leclerc, Dijon; and , Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.

View Article and Find Full Text PDF
October 2018

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

N Engl J Med 2018 08 15;379(8):753-763. Epub 2018 Aug 15.

From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California; the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany; Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France; Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.); and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.).

View Article and Find Full Text PDF
August 2018

Réponse à la lettre d’A. Braillon et F. Taiebi.

Bull Cancer 2018 Jul - Aug;105(7-8):641-642. Epub 2018 Jun 22.

Aix-Marseille université, CNRS, Inserm, institut Paoli-Calmettes, département d'oncologie médicale, CRCM, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. Electronic address:

View Article and Find Full Text PDF
June 2018

[CDK4/6 inhibitors: biomarkers, mechanisms of resistance and interest of the study of the circulating tumor DNA].

Bull Cancer 2018 Jun 2;105(6):545-546. Epub 2018 May 2.

Institut Paoli-Calmettes, département d'oncologie médicale, 232, boulevard de Sainte-Marguerite, Marseille, France. Electronic address:

View Article and Find Full Text PDF
June 2018

[Homeopathy in cancer patients: What does the "best" evidence tell us?]

Bull Cancer 2018 Apr 24;105(4):426-430. Epub 2018 Feb 24.

Aix-Marseille université, institut Paoli-Calmettes, department of medical oncology, CNRS, Inserm, CRCM, 13009 Marseille, France.

View Article and Find Full Text PDF
April 2018

[PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer].

Bull Cancer 2018 Mar 16;105(3):263-274. Epub 2018 Feb 16.

Institut Paoli-Calmettes, département d'oncologie médicale, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, centre de recherche en cancérologie de Marseille, Inserm U1068-CNRS U7258, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, 13009 Marseille, France.

View Article and Find Full Text PDF
March 2018

Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1.

Curr Oncol Rep 2017 Aug 10;19(10):64. Epub 2017 Aug 10.

Department of Medical Oncology, Institut Paoli-Calmettes, 232 Bd. Ste-Marguerite, 13009, Marseille, France.

View Article and Find Full Text PDF
August 2017

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Expert Rev Anticancer Ther 2017 07 25;17(7):593-606. Epub 2017 May 25.

a Department of Medical Oncology, Institut Paoli-Calmettes, Aix Marseille Univ , CNRS U7258, INSERM U1068, CRCM , Marseille , France.

View Article and Find Full Text PDF
July 2017

[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].

Bull Cancer 2017 Apr 16;104(4):332-343. Epub 2017 Feb 16.

Institut Paoli-Calmettes (IPC), département d'oncologie médicale, 232, boulevard de Sainte-Marguerite, 13009 Marseille cedex 9, France; Centre de recherches en cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, Jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille, France. Electronic address:

View Article and Find Full Text PDF
April 2017

Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France.

Med Decis Making 2017 07 15;37(5):555-566. Epub 2017 Feb 15.

Institut Paoli Calmettes, Department of Molecular Oncology, and CRCM, Inserm, U1068; Aix-Marseille Université, UM 105; CNRS, UMR7258, F-13009, Marseille, France (AG, PV).

View Article and Find Full Text PDF
July 2017

[Cancer medicines: reasons for anger].

Rev Prat 2017 02;67(2):141-145

Service d'hématologie clinique, hôpital Pitié-Salpêtrière, université Pierre-et-Marie-Curie, Paris, France.

View Article and Find Full Text PDF
February 2017

Bevacizumab in HER2-negative inflammatory breast cancer.

Oncoscience 2016 15;3(11-12):297-298. Epub 2016 Nov 15.

Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.

View Article and Find Full Text PDF
November 2016

[Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].

Bull Cancer 2017 Jan 19;104(1):6-19. Epub 2016 Dec 19.

CHU de Clermont-Ferrand, service de thérapie cellulaire et d'hématologie clinique adulte, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France.

View Article and Find Full Text PDF
January 2017

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

J Cancer 2016 23;7(14):2077-2084. Epub 2016 Oct 23.

Aix-Marseille Université, Marseille, F-13284, France.; Centre de Thérapie Cellulaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Marseille, F-13273, France.; Centre d'Investigations Cliniques en Biothérapies, Inserm CBT-1409, Marseille, F-13009, France.

View Article and Find Full Text PDF
October 2016

How may targeted proteomics complement genomic data in breast cancer?

Expert Rev Proteomics 2017 01 15;14(1):43-54. Epub 2016 Nov 15.

a Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille Protéomique , Marseille , France.

View Article and Find Full Text PDF
January 2017

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

Eur J Cancer 2016 11 24;67:223. Epub 2016 Sep 24.

Département d'Oncologie Médicale, Institut Paoli-Calmettes (IPC), Marseille, F-13273, France; Centre de Recherches en Cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France. Electronic address:

View Article and Find Full Text PDF
November 2016

[Not Available].

Bull Cancer 2016 Jun;103(6 Suppl 1):S76-89

Département d'oncologie médicale, Institut Paoli-Calmettes, Marseille, 13009; Centre de recherche en cancérologie de Marseille (Institut Paoli-Calmettes, Inserm 1068, Cnrs 7258, Aix-Marseille Université), Marseille, 13009; Aix-Marseille Université, Marseille, 13006. Electronic address:

View Article and Find Full Text PDF
June 2016

[Anticancer drugs: Which prices for therapeutic innovations?].

Bull Cancer 2016 Apr 1;103(4):361-7. Epub 2016 Apr 1.

Aix-Marseille université, 13284 Marseille, France; Institut Paoli-Calmettes, Inserm UMR912 SESSTIM, 13009 Marseille, France.

View Article and Find Full Text PDF
April 2016

Comparative genomic analysis of primary tumors and metastases in breast cancer.

Oncotarget 2016 May;7(19):27208-19

Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France.

View Article and Find Full Text PDF
May 2016

[Financial stress: A prognostic factor for cancer survival!].

Bull Cancer 2016 Apr 24;103(4):318. Epub 2016 Mar 24.

Institut Paoli-Calmettes, centre de recherche en cancérologie de Marseille, Inserm U1068, CNRS U7258, Aix-Marseille Université, 232, boulevard Sainte-Marguerite, 13009 Marseille, France. Electronic address:

View Article and Find Full Text PDF
April 2016

Survival impact and predictive factors of axillary recurrence after sentinel biopsy.

Eur J Cancer 2016 May 11;58:73-82. Epub 2016 Mar 11.

Institut Paoli Calmettes and CRCM, 232 Bd Ste Marguerite, 13009 Marseille, France; Institut Paoli Calmettes, Biostatistic Department, 232 Bd Ste Marguerite, 13009 Marseille, France; Aix Marseille Université, 25 Bd Jean Moulin, 13005 Marseille, France.

View Article and Find Full Text PDF
May 2016

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

Eur J Cancer 2016 04 23;57:118-26. Epub 2016 Feb 23.

Département d'Oncologie Médicale, Institut Paoli-Calmettes (IPC), Marseille, F-13273, France; Centre de Recherches en Cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France. Electronic address:

View Article and Find Full Text PDF
April 2016

[2015 through the eyes of the Bulletin of Cancer editorial board].

Bull Cancer 2016 Jan 15;103(1):3-17. Epub 2016 Jan 15.

Hôpitaux de Chartres, service oncologie hématologie, , site Louis-Pasteur, 28630 Chartres-Le-Coudray, France.

View Article and Find Full Text PDF
January 2016